These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1093 related articles for article (PubMed ID: 15964501)
1. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Jones RN; Fritsche TR; Sader HS Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501 [TBL] [Abstract][Full Text] [Related]
2. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN; Sader HS; Stilwell MG; Fritsche TR Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904 [TBL] [Abstract][Full Text] [Related]
3. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Jones RN; Fritsche TR; Sader HS; Stilwell MG Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903 [TBL] [Abstract][Full Text] [Related]
4. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Biedenbach DJ; Toleman MA; Walsh TR; Jones RN Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373 [TBL] [Abstract][Full Text] [Related]
5. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Johnson DM; Stilwell MG; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341 [TBL] [Abstract][Full Text] [Related]
6. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004). Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN; Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN; Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Biedenbach DJ; Toleman M; Walsh TR; Jones RN Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025 [TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
10. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN; J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program. Castanheira M; Gales AC; Mendes RE; Jones RN; Sader HS Clin Microbiol Infect; 2004 Jul; 10(7):645-51. PubMed ID: 15214878 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306 [TBL] [Abstract][Full Text] [Related]
13. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for pneumococcal pneumonia in Turkey. Oncu S; Erdem H; Pahsa A Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005. Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469 [TBL] [Abstract][Full Text] [Related]
17. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Morrissey I; Colclough A; Northwood J Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269 [TBL] [Abstract][Full Text] [Related]
18. Resistance among Streptococcus pneumoniae: Implications for drug selection. Appelbaum PC Clin Infect Dis; 2002 Jun; 34(12):1613-20. PubMed ID: 12032897 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Doern GV; Richter SS; Miller A; Miller N; Rice C; Heilmann K; Beekmann S Clin Infect Dis; 2005 Jul; 41(2):139-48. PubMed ID: 15983908 [TBL] [Abstract][Full Text] [Related]
20. Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001. Davies TA; Yee YC; Goldschmidt R; Sahm DF; Evangelista AT Postgrad Med; 2008 Sep; 120(3 Suppl 1):39-45. PubMed ID: 18931470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]